// App-Quantinova.ai

2367 : Thrombin Generation Test During Asparaginase Treatment In Children With Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Laurence Rozen

Principal Investigators

  • Denis F Noubouossie

  • Laurence Dedeken

  • Sophie Huybrechts

  • Phu-Quoc Le

  • Alina Ferster

  • Anne Demulder

Medical Centers

  • Pediatric Hematology, Hopital Universitaire des Enfants Reine Fabiola, Universite Libre de Bruxelles, Brussels, Belgium

  • Laboratory of Hematology and Hemostasis, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium

  • Haematology/Haemostasis Lab, CHU Brugmann, Brussels, Belgium

  • Pediatric Hematology, Hopital Universitaire des Enfants Reine Fabiola, Universite Libre de Bruxelles, Brussels, Belgium

  • Pediatric Hematology, Hopital Universitaire des Enfants Reine Fabiola, Universite Libre de Bruxelles, Brussels, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute lymphoblastic leukemia

  • Venous thrombosis

Biomarkers

  • Breakpoint Cluster Region

  • Nucleoside diphosphate kinase A

  • Catalase

  • Protein S

  • Fibrinogen

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Thrombomodulin alfa

  • Asparaginase

  • Fibrinogen (IV)

  • Protein C

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved